Just one large IPO priced this past week, while the other scheduled deal was pulled. Two blank checks also began trading. Precision medicine company Tempus AI (TEM) priced at the high end to raise $411 million at a $6.4 billion market cap. The...read more
Experienced sponsors are moving back into the SPAC market as blank check issuance has stabilized, a signal that the space has found its footing more than two years after SPAC mania ended. To some extent, they never left: Several of the largest SPAC IPOs in...read more
One IPO debuted this past week. Three IPOs and two SPACs submitted initial filings. Specialty property & casualty insurer Bowhead Specialty Holdings (BOW) priced its upsized IPO at the top of the range to raise $128 million at a $551 million market cap....read more
US IPO Weekly Recap: Precision medicine IPO Tempus AI posts a modest gain in its debut
Just one large IPO priced this past week, while the other scheduled deal was pulled. Two blank checks also began trading. Precision medicine company Tempus AI (TEM) priced at the high end to raise $411 million at a $6.4 billion market cap. The...read more
Back in SPACs: Experienced sponsors return to the SPAC market
Experienced sponsors are moving back into the SPAC market as blank check issuance has stabilized, a signal that the space has found its footing more than two years after SPAC mania ended. To some extent, they never left: Several of the largest SPAC IPOs in...read more
Tech SPAC Centurion Acquisition prices $250 million IPO
...read more
US IPO Weekly Recap: Specialty insurer Bowhead sole IPO to debut as more names join the pipeline
One IPO debuted this past week. Three IPOs and two SPACs submitted initial filings. Specialty property & casualty insurer Bowhead Specialty Holdings (BOW) priced its upsized IPO at the top of the range to raise $128 million at a $551 million market cap....read more